Chugai Pharmabody Research
Charlotte Guetta-Terrier is a Senior Scientist I at Chugai Pharmabody Research since May 2022. Prior to this role, Charlotte served as a Post Doctoral Research Associate at Brown University from March 2017 to May 2022 and completed a Ph.D. in Biophysics and Molecular Biology at the National University of Singapore between 2012 and 2016, where involvement as a Ph.D. student took place from January 2012 to December 2016. Earlier academic credentials include an M2 degree in Biophysique from Paris-Sud University (Paris XI), earned from 2008 to 2011.
This person is not in any offices
Chugai Pharmabody Research
1 followers
In the global medical field, there are many diseases in which there are no drug or current drugs are insufficient to address the medical needs of patients. Chugai Pharmabody Research (CPR) is a subsidiary company of Chugai Pharmaceutical in Japan, a member of Roche group, and is committed to address these unmet needs by specializing in the field of antibody drug discovery utilizing proprietary antibody engineering technologies.